Stemtech Corp STEK
We take great care to ensure that the data presented and summarized in this overview for Stemtech Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in STEK
Top Purchases
Top Sells
About STEK
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its dietary supplement products under the RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze brands. The company is based in Miramar, Florida.
Insider Transactions at STEK
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 26
2024
|
Charles Stuart Arnold Director |
BUY
Open market or private purchase
|
Indirect |
25,000
+1.38%
|
$0
$0.05 P/Share
|
Apr 19
2024
|
Mindshare Holdings, Inc. |
SELL
Open market or private sale
|
Direct |
25,000
-1.02%
|
$0
$0.06 P/Share
|
Aug 08
2023
|
Darryl V Green Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,254,818
+24.04%
|
$0
$0.05 P/Share
|
Jun 12
2023
|
Darryl V Green Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,408,818
+47.07%
|
$0
$0.05 P/Share
|
Jun 12
2023
|
Charles Stuart Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,333,333
+35.0%
|
$0
$0.05 P/Share
|
Last 12 Months Summary
Open market or private purchase | 25K shares |
---|
Open market or private sale | 25K shares |
---|